Evidence map›Paper›PMID 36449522›Full record

ArticlePloS one2022

Optimized conditions for Listeria, Salmonella and Escherichia whole genome sequencing using the Illumina iSeq100 platform with point-and-click bioinformatic analysis.

Sonsiray Alvarez Narvaez, Zhenyu Shen, Lifang Yan, Brianna L S Stenger, Laura B Goodman, Ailam Lim, Ruth H Nissly, Meera Surendran Nair, Shuping Zhang, Susan Sanchez

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Predicting Antibiotic Resistance inInternational journal of molecular sciences · 2025
    Pooled it
  2. Hybrid genomes of three multidrug-resistantMicrobiology resource announcements · 2026
    Article
  3. Article
  4. No evidence of multidrug-resistantMicrobiology spectrum · 2025
    Observational
  5. Antibiotics (Basel, Switzerland) · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sonsiray Alvarez NarvaezDepartment of Population Health, College of Veterinary Medicine, The University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-5353-2081
Zhenyu ShenDepartment of Veterinary Pathology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United States of America.
Lifang YanDepartment of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi, United States of America.
Brianna L S StengerVeterinary Diagnostic Laboratory, North Dakota Agricultural Experiment Station, North Dakota State University, Fargo, North Dakota, United States of America.
Laura B GoodmanDepartment of Public & Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Ailam LimWisconsin Veterinary Diagnostic Laboratory, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0003-1546-5401
Ruth H NisslyDepartment of Veterinary and Biomedical Sciences, College of Agricultural Sciences, PennState University, State College, Pennsylvania, United States of America.ORCID 0000-0002-3102-7447
Meera Surendran NairDepartment of Veterinary and Biomedical Sciences, College of Agricultural Sciences, PennState University, State College, Pennsylvania, United States of America.
Shuping ZhangDepartment of Veterinary Pathobiology, Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United States of America.
Susan SanchezDepartment of Infectious Disease, College of Veterinary Medicine, The University of Georgia, Athens, Georgia, United States of America.

Funding

One Health; Epidemiology of natural and deliberate contaminants (infectious and toxicities) in animals and animal foodU18FD006157 · FDA · UNIVERSITY OF GEORGIA · PI Binu Velayudhan · 2017 to 2026
$434k
FDA HHS U18 FD006157
6 · The paper itself

Abstract

Whole-genome sequencing (WGS) data have become an integral component of public health investigations and clinical diagnostics. Still, many veterinary diagnostic laboratories cannot afford to implement next generation sequencing (NGS) due to its high cost and the lack of bioinformatic knowledge of the personnel to analyze NGS data. Trying to overcome these problems, and make NGS accessible to every diagnostic laboratory, thirteen veterinary diagnostic laboratories across the United States (US) initiated the assessment of Illumina iSeq100 sequencing platform for whole genome sequencing of important zoonotic foodborne pathogens Escherichia coli, Listeria monocytogenes, and Salmonella enterica. The work presented in this manuscript is a continuation of this multi-laboratory effort. Here, seven AAVLD accredited diagnostic laboratories explored a further reduction in sequencing costs and the usage of user-friendly platforms for genomic data analysis. Our investigation showed that the same genomic library quality could be achieved by using a quarter of the recommended reagent volume and, therefore a fraction of the actual price, and confirmed that Illumina iSeq100 is the most affordable sequencing technology for laboratories with low WGS demand. Furthermore, we prepared step-by-step protocols for genomic data analysis in three popular user-friendly software (BaseSpace, Geneious, and GalaxyTrakr), and we compared the outcomes in terms of genome assembly quality, and species and antimicrobial resistance gene (AMR) identification. No significant differences were found in assembly quality, and the three analysis methods could identify the target bacteria species. However, antimicrobial resistance genes were only identified using BaseSpace and GalaxyTrakr; and GalaxyTrakr was the best tool for this task.

Indexed as

ListeriaAnti-Bacterial AgentsComputational BiologyEscherichia coliHigh-Throughput Nucleotide SequencingSalmonellaWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID36449522
PMCPMC9710801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.